Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Paul L. Schaefer"'
Autor:
Terence M. Williams, Chandan Guha, Kent A. Griffith, Kathryn Winter, Samir Narayan, William Small, Mitchel Fromm, Thomas A. DiPetrillo, Paul L. Schaefer, Dafydd Thomas, Meredith Morgan, Ross Abrams, William F. Regine, Asha George, Edgar Ben-Josef
Table S1. Distribution of GSK3β Expression (fluorescence intensity units) for Patients Entered on RTOG 97-04 (n=163)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c4819dd80191ffc86332820da60d51
https://doi.org/10.1158/1078-0432.22461479
https://doi.org/10.1158/1078-0432.22461479
Autor:
Terence M. Williams, Chandan Guha, Kent A. Griffith, Kathryn Winter, Samir Narayan, William Small, Mitchel Fromm, Thomas A. DiPetrillo, Paul L. Schaefer, Dafydd Thomas, Meredith Morgan, Ross Abrams, William F. Regine, Asha George, Edgar Ben-Josef
Figure S1. Exploratory analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d33f2c70466f08bc34e5b9d0a89294c
https://doi.org/10.1158/1078-0432.22461485.v1
https://doi.org/10.1158/1078-0432.22461485.v1
Autor:
Terence M. Williams, Chandan Guha, Kent A. Griffith, Kathryn Winter, Samir Narayan, William Small, Mitchel Fromm, Thomas A. DiPetrillo, Paul L. Schaefer, Dafydd Thomas, Meredith Morgan, Ross Abrams, William F. Regine, Asha George, Edgar Ben-Josef
Legend for Figure S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec23864a970d3cfbff59a8753d7b1a3
https://doi.org/10.1158/1078-0432.22461482.v1
https://doi.org/10.1158/1078-0432.22461482.v1
Autor:
Paul L. Schaefer, Xiyong Liu, Gerold Bepler, Jonathan L. Wong, Hany Elsaleh, Zhong Zheng, Raymond Lai, Yun Yen, Jennifer Moughan, Al B. Benson, William F. Regine, Chandan Guha, James J. Farrell, John S. Macdonald
Publikováno v:
Pancreas. 45:1485-1493
Objectives There is a need for validated predictive markers of gemcitabine response to guide precision medicine treatment in pancreatic cancer. We previously validated human equilibrative nucleoside transporter 1 as a predictive marker of gemcitabine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e31027bbb2b0f00f13f5891a4d4934c6
https://doi.org/10.1097/mpa.0000000000000710
https://doi.org/10.1097/mpa.0000000000000710
Autor:
William F. Regine, Terence M. Williams, Mitchel Fromm, Asha George, Kent A. Griffith, Chandan Guha, Paul L. Schaefer, Meredith A. Morgan, William Small, Samir Narayan, Ross A. Abrams, Kathryn Winter, Dafydd G. Thomas, Thomas A. DiPetrillo, Edgar Ben-Josef
Publikováno v:
Clinical Cancer Research. 21:5612-5618
Purpose: GSK3β is a protein kinase that can suppress a number of key oncoproteins. We have previously shown in preclinical models of pancreatic ductal adenocarcinoma (PDAC) that inhibition of GSK3β causes stabilization and nuclear translocation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ad54aa179161518ef492e3e087d680
https://doi.org/10.1158/1078-0432.ccr-15-0789
https://doi.org/10.1158/1078-0432.ccr-15-0789
Autor:
C. D. James, Caterina Giannini, Jan C. Buckner, Joon H. Uhm, Wenting Wu, John C. Krauss, Bernd W. Scheithauer, Paul L. Schaefer, Shaker R. Dakhill, Karla V. Ballman, Kurt A. Jaeckle, Robert J. Behrens, Patrick J. Flynn
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 80:347-353
Purpose: Amplification of the epidermal growth factor receptor (EGFR) gene represents one of the most frequent gene alterations in glioblastoma (GBM). In the current study, we evaluated gefitinib, a potent EGFR inhibitor, in the treatment of adults w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ebae8793985817098609c534ae60ef3
https://doi.org/10.1016/j.ijrobp.2010.01.070
https://doi.org/10.1016/j.ijrobp.2010.01.070
Autor:
Howard M. Gross, Charles L. Loprinzi, Donald B. Wender, Paul L. Schaefer, John W. Kugler, Aminah Jatoi, Paul J. Novotny, Jeff A. Sloan, Shaker R. Dakhil, Kendrith M. Rowland
Publikováno v:
Supportive Care in Cancer. 19:1601-1607
Purpose Previous studies suggest tetracycline and other antibiotics lessen the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash. This study sought to confirm such findings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5af2e81fe451d75306a8c944ef1c97b
https://doi.org/10.1007/s00520-010-0988-5
https://doi.org/10.1007/s00520-010-0988-5
Autor:
Shuji Ogino, Richard M. Goldberg, Alexander Hantel, Al B. Benson, Paul L. Schaefer, Monica M. Bertagnolli, Renaud Whittom, Leonard B. Saltz, Robert J. Mayer, Donna Hollis, Donna Niedzwiecki, Natsumi Irahara, Charles S. Fuchs, Jeffrey A. Meyerhardt
Publikováno v:
Clinical Cancer Research. 15:7322-7329
Purpose: Alterations in the RAS and RAF pathway relate to epigenetic and epigenomic aberrations, and are important in colorectal carcinogenesis. KRAS mutation in metastatic colorectal cancer predicts resistance to anti–epidermal growth factor recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e5f8b489c866dad1df3f9218662ff1
https://doi.org/10.1158/1078-0432.ccr-09-1570
https://doi.org/10.1158/1078-0432.ccr-09-1570
Autor:
Ming Wen An, Paul L. Schaefer, Michael J. O'Connell, Shauna L. Hillman, Daniel J. Sargent, Jan C. Buckner, Richard M. Goldberg
Publikováno v:
Journal of Clinical Oncology. 27:3205-3210
Purpose In February 2000, the criteria for measuring tumor shrinkage as an indicator of antitumor activity were redefined by the Response Evaluation Criteria in Solid Tumors (RECIST). This resulted in simplifying bidimensional to unidimensional measu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3ceb5d1648e7640ef895ce1359b23c9
https://doi.org/10.1200/jco.2008.18.3269
https://doi.org/10.1200/jco.2008.18.3269
Autor:
Stephanie L. Hines, Miroslaw Mazurczak, Steve R. Alberts, Edith A. Perez, David B. Johnson, S. P. Kahanic, Daniel A. Nikcevich, Betty A. Mincey, Heshan Liu, Jeff A. Sloan, Todor Dentchev, Charles L. Loprinzi, Paul L. Schaefer
Publikováno v:
Breast Cancer Research and Treatment. 117:603-609
Postmenopausal women with breast cancer (BC) are at increased risk for bone loss. Bisphosphonates improve bone mineral density (BMD) in normal postmenopausal women. The purpose of this study was to determine if immediate treatment with zoledronic aci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373da3c66f75b9b20d468580a0a4ac19
https://doi.org/10.1007/s10549-009-0332-2
https://doi.org/10.1007/s10549-009-0332-2